127 related articles for article (PubMed ID: 33300632)
1. Adverse reactions to 1% cyclopentolate eye drops in children: an analysis using logistic regression models.
Imai T; Hasebe S; Furuse T; Morisawa S; Hasebe K; Nagata Y; Tokutake T; Moriyama Y
Ophthalmic Physiol Opt; 2021 Mar; 41(2):424-430. PubMed ID: 33300632
[TBL] [Abstract][Full Text] [Related]
2. Incidence of side effects of topical atropine sulfate and cyclopentolate hydrochloride for cycloplegia in Japanese children: a multicenter study.
Wakayama A; Nishina S; Miki A; Utsumi T; Sugasawa J; Hayashi T; Sato M; Kimura A; Fujikado T
Jpn J Ophthalmol; 2018 Sep; 62(5):531-536. PubMed ID: 30046935
[TBL] [Abstract][Full Text] [Related]
3. Adverse reactions following routine anticholinergic eye drops in a paediatric population: an observational cohort study.
van Minderhout HM; Joosse MV; Grootendorst DC; Schalij-Delfos NE
BMJ Open; 2015 Dec; 5(12):e008798. PubMed ID: 26700273
[TBL] [Abstract][Full Text] [Related]
4. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial.
Bagheri A; Givrad S; Yazdani S; Reza Mohebbi M
Eur J Ophthalmol; 2007; 17(3):294-300. PubMed ID: 17534806
[TBL] [Abstract][Full Text] [Related]
5. Cycloplegic refractions in Japanese children: a comparison of atropine and cyclopentolate.
Kawamoto K; Hayasaka S
Ophthalmologica; 1997; 211(2):57-60. PubMed ID: 9097304
[TBL] [Abstract][Full Text] [Related]
6. Factors Affecting Pupil Reactivity After Cycloplegia in Asian Children.
Lim J; Chia A; Saffari SE; Handa S
Asia Pac J Ophthalmol (Phila); 2019; 8(4):304-307. PubMed ID: 31385819
[TBL] [Abstract][Full Text] [Related]
7. Cycloplegic Refraction in Hyperopic Children: Effectiveness of a 0.5% Tropicamide and 0.5% Phenylephrine Addition to 1% Cyclopentolate Regimen.
Yoo SG; Cho MJ; Kim US; Baek SH
Korean J Ophthalmol; 2017 Jun; 31(3):249-256. PubMed ID: 28471102
[TBL] [Abstract][Full Text] [Related]
8. Acute psychotic reaction caused by topical cyclopentolate use for cycloplegic refraction before refractive surgery: case report and review of the literature.
Mirshahi A; Kohnen T
J Cataract Refract Surg; 2003 May; 29(5):1026-30. PubMed ID: 12781295
[TBL] [Abstract][Full Text] [Related]
9. [Influence of the instillation of two versus three eyedrops of cyclopentolate 0.5% on refraction of Caucasian nonstrabismic children].
Gadioux-Madern F; Lelez ML; Sellami L; Santallier M; Fourquet F; Pisella PJ; Arsene S
J Fr Ophtalmol; 2008 Jan; 31(1):51-5. PubMed ID: 18401299
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of a Cycloplegic Agent Administered as a Spray in the Pediatric Population.
Vagge A; Del Noce C; Pellegrini M; Cappelli F; Musolino M; Bernabei F; Giannaccare G; Traverso CE
J Pediatr Ophthalmol Strabismus; 2020 Sep; 57(5):301-304. PubMed ID: 32956479
[TBL] [Abstract][Full Text] [Related]
11. EEG changes as an indication of central nervous system involvement following cyclopentolate 1% eye drops; a randomized placebo-controlled pilot study in a pediatric population.
van Minderhout HM; Joosse MV; Klaassen ES; Schalij-Delfos NE
Strabismus; 2023 Jun; 31(2):82-96. PubMed ID: 37282618
[TBL] [Abstract][Full Text] [Related]
12. A Clinical Randomized Trial Comparing the Cycloplegic Effect of Cyclopentolate Drops Applied to Closed Eyelids Versus Open Eyelids.
Zurevinsky J; Sawchuk K; Lim HJ; Lee CH; Rubab S
Am Orthopt J; 2016 Jan; 66(1):114-121. PubMed ID: 27799585
[TBL] [Abstract][Full Text] [Related]
13. Retinoscopy in infants using a near noncycloplegic technique, cycloplegia with tropicamide 1%, and cycloplegia with cyclopentolate 1%.
Twelker JD; Mutti DO
Optom Vis Sci; 2001 Apr; 78(4):215-22. PubMed ID: 11349929
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cycloplegia at 20- and 30-minutes following proxymetacaine and cyclopentolate instillation in white 12-13-year-olds.
Doyle M; O' Dwyer V; Harrington S
Clin Exp Optom; 2023 Nov; 106(8):890-895. PubMed ID: 36750050
[TBL] [Abstract][Full Text] [Related]
15. Epileptic seizures induced by cycloplegic eye drops.
Wygnanski-Jaffe T; Nucci P; Goldchmit M; Mezer E
Cutan Ocul Toxicol; 2014 Jun; 33(2):103-8. PubMed ID: 23815170
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Cyclopentolate on Ocular Biometric Components.
Hashemi H; Asharlous A; Khabazkhoob M; Iribarren R; Khosravi A; Yekta A; Emamian MH; Fotouhi A
Optom Vis Sci; 2020 Jun; 97(6):440-447. PubMed ID: 32511166
[TBL] [Abstract][Full Text] [Related]
17. A prospective comparison between cyclopentolate spray and drops in pediatric outpatients.
Syrimi M; Jones SM; Thompson GM
J Pediatr Ophthalmol Strabismus; 2013; 50(5):290-5. PubMed ID: 23705592
[TBL] [Abstract][Full Text] [Related]
18. Randomised controlled pilot trial comparing low dose and very low- dose microdrop administration of phenylephrine and cyclopentolate for retinopathy of prematurity eye examinations in neonates.
Kremer LJ; Broadbent R; Medlicott N; Sime MJ; McCaffrey F; Reith DM
Arch Dis Child; 2021 Jun; 106(6):603-608. PubMed ID: 33051215
[TBL] [Abstract][Full Text] [Related]
19. Cycloplegia in African-American children.
Kleinstein RN; Mutti DO; Manny RE; Shin JA; Zadnik K
Optom Vis Sci; 1999 Feb; 76(2):102-7. PubMed ID: 10082056
[TBL] [Abstract][Full Text] [Related]
20. Influence of the time interval between instillation of two drops of cyclopentolate 1% on refraction and dilation of the pupil in children.
Stolovitch C; Alster Y; Loewenstein A; Lazar M
Am J Ophthalmol; 1995 May; 119(5):637-9. PubMed ID: 7733189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
